News & Updates

Patients with stroke-heart syndrome (SHS) may have increased risk of dementia in the early phase after a stroke, but this risk can be lowered to a level similar to those without SHS if adherent care is given, researchers from the University of Hong Kong (HKU) and their international collaborators have found.

Cognitive behavioural therapy (CBT) for insomnia (CBT-I) helps reduce its severity and improve other sleep outcomes in patients with chronic disease, such as chronic pain, cardiovascular disease, and cancer, according to the results of a meta-analysis.

A recent study has shown infliximab’s superiority over adalimumab in the treatment of bio-naïve patients with fistulizing Crohn’s disease (FCD). However, there is no therapeutic difference seen in bio-exposed FCD.

Higher levels of oxidative balance score (OBS) are associated with a lower risk of advanced cardiovascular‒kidney‒metabolic (CKM) syndrome, reveals a study.

Treatment with the novel cannabinoid receptor 1 (CB1R) inverse agonist monlunabant appears to yield significant and clinically meaningful weight loss in adults with obesity and metabolic syndrome, according to a phase IIa trial.

Menopause is not the main driver of worsening disability in older women with multiple sclerosis (MS), as shown in a retrospective study.

Compared with intravenous (IV) or oral glucocorticoids (GCs), the use of teprotumumab results in lower risks of mortality and cardiovascular, renal, and infectious outcomes in patients with thyroid eye disease (TED), suggests a study.